Point-of-care demand Target health systems and urgent care networks emphasizing rapid infectious disease testing at the point of care, highlighting Talis One as a solution to replace centralized lab delays and enable same-visit treatment decisions.

Laboratory footprint decline With reports of closed laboratories and downsizing, position alternative integration options for mobile clinics, rural health providers, and underserved areas that need compact, on-site diagnostic capabilities.

Executive leadership Engage with recent appointees (president and CSO) and governance leaders to align strategic partnerships, co-develop clinical validation programs, and secure endorsements for market entry in new regions.

Clinical validation needs Highlight opportunities to collaborate on rapid, lab-quality molecular assay validation, quality assurance programs, and regulatory clearance support to accelerate adoption in hospital and ASC settings.

Growth through equity Leverage the health equity mission to pursue contracts with safety-net hospitals, public health programs, and community clinics, emphasizing fast-result testing to improve patient outcomes and reduce antimicrobial resistance spread.